Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'Crammed into a cell with vermin at New Year' - 2Watch the Geminid meteor shower peak tonight from the comfort of home with this free livestream
- 3The 10 Most Noteworthy Games in History
- 4From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
- 5Fundamental Monetary Guidance for Going into Business
- How Mars 'punches above its weight' to influence Earth's climate
- New science points to 4 distinct types of autism
- Dick Van Dyke shares his secrets to longevity as he turns 100
- Dominating Capable Mastercard Utilization: Key Contemplations
- Zelensky sees new Russian attack threat from Belarus
- Reporter's notebook: Inside the IDF’s ‘Hamas Village,’ and how Israel is rewriting urban warfare
- The most effective method to Go with Informed Choices on Vehicle Leases
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- November Lease Deals for the 2025 Kia EV6 are Too Good to Pass Up
